Altered effector function of peripheral cytotoxic cells in COPD
Open Access
- 22 June 2009
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 10 (1) , 53
- https://doi.org/10.1186/1465-9921-10-53
Abstract
There is mounting evidence that perforin and granzymes are important mediators in the lung destruction seen in COPD. We investigated the characteristics of the three main perforin and granzyme containing peripheral cells, namely CD8+ T lymphocytes, natural killer (NK; CD56+CD3-) cells and NKT-like (CD56+CD3+) cells. Peripheral blood mononuclear cells (PBMCs) were isolated and cell numbers and intracellular granzyme B and perforin were analysed by flow cytometry. Immunomagnetically selected CD8+ T lymphocytes, NK (CD56+CD3-) and NKT-like (CD56+CD3+) cells were used in an LDH release assay to determine cytotoxicity and cytotoxic mechanisms were investigated by blocking perforin and granzyme B with relevant antibodies. The proportion of peripheral blood NKT-like (CD56+CD3+) cells in smokers with COPD (COPD subjects) was significantly lower (0.6%) than in healthy smokers (smokers) (2.8%, p < 0.001) and non-smoking healthy participants (HNS) (3.3%, p < 0.001). NK (CD56+CD3-) cells from COPD subjects were significantly less cytotoxic than in smokers (16.8% vs 51.9% specific lysis, p < 0.001) as were NKT-like (CD56+CD3+) cells (16.7% vs 52.4% specific lysis, p < 0.001). Both cell types had lower proportions expressing both perforin and granzyme B. Blocking the action of perforin and granzyme B reduced the cytotoxic activity of NK (CD56+CD3-) and NKT-like (CD56+CD3+) cells from smokers and HNS. In this study, we show that the relative numbers of peripheral blood NK (CD56+CD3-) and NKT-like (CD56+CD3+) cells in COPD subjects are reduced and that their cytotoxic effector function is defective.Keywords
This publication has 45 references indexed in Scilit:
- Killer cells in chronic obstructive pulmonary diseaseClinical Science, 2008
- COPD as a Systemic DiseaseCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2008
- Systemic Effects of Chronic Obstructive Pulmonary Disease: What We Know and What We Don't Know (but Should)Proceedings of the American Thoracic Society, 2007
- Perforin, granzyme B, and FasL expression by peripheral blood T lymphocytes in emphysemaRespiratory Research, 2007
- From COPD to chronic systemic inflammatory syndrome?The Lancet, 2007
- Invariant Natural Killer T Cells in Asthma and Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2007
- Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary diseaseClinical and Experimental Immunology, 2006
- Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokersEuropean Respiratory Journal, 2005
- Small Airways in COPDNew England Journal of Medicine, 2004
- Functionally Distinct Subsets of CD1d-restricted Natural Killer T Cells Revealed by CD1d Tetramer StainingThe Journal of Experimental Medicine, 2002